Posts

Menkes Disease Drug Treatment Market Poised To Grow At A Robust Pace Due To Increasing Prevalence Of Menkes Disease

Image
  Menkes disease, a rare X-linked genetic disorder affecting copper metabolism caused by mutations in ATP7A gene, leads to impaired absorption and transport of dietary copper in the body. Patients suffering from Menkes disease exhibit neurodegenerative features and connective tissue abnormalities. Drug treatment options such as copper histidine, copper chloride, and zinc acetate are used to manage the symptoms of Menkes disease. The Menkes Disease Market is estimated to be valued at US$ 165.1 million in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period of 2024-2031. The need for drugs to manage copper deficiency and improve health outcomes in patients suffering from Menkes disease is driving market growth. Key Takeaways Key players operating in the Menkes disease drug treatment market are Fortress Biotech, Inc., Teva Pharmaceutical Industries Ltd.,Amerigen Pharmaceuticals Limited, Mylan N.V., Bausch Health Companies Inc. Fortress Biotech is advancing a ge
Post a Comment
Read more

Medical Suction Devices Market Is Anticipated To Witness High Growth Owing To Rising Prevalence Of Chronic Diseases

Image
The medical suction devices market includes products used for removing gases, fluids, vomit, or secretions from the respiratory tract, including the mouth, pharynx, trachea, bronchi or lungs. There are various types of medical suction devices available in the market including electric suction machines, battery-powered portable suction machines and disposable/single use suction catheters. These suction devices find applications during surgical procedures, in emergency care situations, in ICUs and in home care settings for patients requiring respiratory care. With rising cases of respiratory diseases, growing elderly population suffering from chronic obstructive pulmonary diseases and the continued prevalence of COVID-19, demand for medical suction devices is surging. This has prompted manufacturers to advance their products by incorporating features including variable suction control, bacteria filters and compatibility with oxygen therapy. The Medical Suction Devices Market is estimat
Post a Comment
Read more

Malabsorption Syndrome Market Faces High Growth Due To Rising Prevalence Of Digestive Disorders

Image
Malabsorption syndrome refers to a group of disorders where the small intestine does not absorb enough nutrients, vitamins or minerals from food. The most common causes of malabsorption syndrome are celiac disease, inflammatory bowel disease (IBD), pancreatic insufficiency and short bowel syndrome. The growing prevalence of digestive disorders such as celiac disease and IBD along with increasing demand for targeted medications to treat underlying causes are key factors fueling the demand for malabsorption syndrome treatments. The Malabsorption Syndrome Market is estimated to be valued at US$ 3.42 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031. Key Takeaways Key players operating in the malabsorption syndrome market are AbbVie Inc., Immunogen X, LLC, Astra Zeneca, ImmusanT, Inc., Ritter Pharmaceuticals. These players are focused on developing novel therapeutics and expand their geographic presence globally. The growing prevalence of auto
Post a Comment
Read more

Liver Cirrhosis Treatment Market Is Anticipated To Witness Growth Owing To Rising Prevalence Of Liver Diseases

Image
Liver cirrhosis refers to scarring of the liver caused by long-term liver damage and disease. Some of the common causes include excessive alcohol consumption, viral hepatitis, non-alcoholic fatty liver disease and others. Treatment for liver cirrhosis involves management of symptoms, treatment of underlying cause and mitigating further liver damage. The Liver Cirrhosis Market is primarily driven by increasing prevalence of chronic liver diseases and technological advancements in treatment options. The Liver Cirrhosis Market is estimated to be valued at US$ 1.41 Bn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031. Liver cirrhosis treatment products aim to minimize liver damage, prevent further scarring and prolong survival. Some of the key products in the market include antiviral drugs, alcohol deterrent medications, corticosteroids, chemotherapy and liver transplantation. With rising healthcare expenditure and improved access to diagnosis and c
Post a Comment
Read more

Global Ophthalmoplegia Market Is Anticipated To Witness High Growth Owing To Rising Prevalence Of Eye Disorders

Image
Ophthalmoplegia refers to a paralysis of one or more of the extraocular muscles that are involved in eye movement. The condition is often caused due to various factors such as myasthenia gravis, thyroid eye disease, brainstem lesions, or nerve damage during surgeries. Some of the key symptoms of ophthalmoplegia include double vision, ocular misalignment, inability to fully move the eyes in certain directions, etc. The rising prevalence of various eye diseases and disorders that can potentially lead to ophthalmoplegia is driving the need for effective treatment options. The global ophthalmoplegia market witnesses high demand for advanced medications, surgical techniques, and eye exercise therapies for managing the condition. The market is estimated to be valued at US$ 510 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031. Key Takeaways Key players operating in the Global Ophthalmoplegia Market are Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd.
Post a Comment
Read more

Global Blood Brain Barrier Market Is Anticipated To Witness High Growth Owing To Growing Research And Developments In Neurological Disorders

Image
The catering to this market include monoclonal antibodies, liposomes, nanoparticles, receptor-mediated transcytosis, and iontophoresis which aid in transporting different therapeutic agents across the blood brain barrier for treating neurological conditions such as meningitis, multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, and brain tumors. The need for such solutions arises due to the inability of large molecule drugs and over 98% of small molecule drugs to cross the blood brain barrier. The Global Blood Brain Barrier Market is estimated to be valued at US$ 36.2 Mn in 2024 and is expected to exhibit a CAGR of 49% over the forecast period 2024-2031. Key Takeaways Key players operating in the global blood brain barrier market are Denali Therapeutics, JCR Pharmaceuticals, Cyclenium Pharma, Lauren Sciences, biOasis Technologies. Denali Therapeutics is a leading biotech company focusing on developing treatments for neurodegenerative diseases. JCR Pha
Post a Comment
Read more

Cell Cytometry Market Is Anticipated To Witness High Growth Owing To Rising Adoption Of Cell Culture Techniques

Image
Cell cytometry technologies help in characterization, counting and sorting of cells based on their physical and chemical properties including size, shape and internal complexity. Cell cytometry finds applications across various disciplines including stem cell research, immunology, cancer research, transplant quality control, and clinical diagnostics. The technique allows multiparametric analysis of individual cells at a high speed and helps in gaining a better understanding of cells at the single cell level. Rising adoption of cell culture techniques across industries such as biotechnology and pharmaceutical is anticipated to drive the growth of the cell cytometry market during the forecast period. The Cell Cytometry Market is estimated to be valued at US$ 1.5 Bn in 2024 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024-2031. Key Takeaways Key players operating in the cell cytometry market are Agilent, Beckton Dickinson, Beckman Coulter Life Sciences, Bio-Ra
Post a Comment
Read more